SPONSOR
Centre Hospitalier Universitaire Dijon
Total Trials
13
Recruiting
13
Phases
Phase 3
Conditions studied: Pathological Use of Internet GamesCVA, Dijon RegistryType 2 DiabetesFoot WoundRare Diseases of Genetic OriginRare Forms of Common Diseases Suspected of Being Genetic in OriginMetastatic Non-small Cell Lung CancerType 1 DiabetesNeurodevelopmental Motor DisordersMild Cognitive Disorder
Centre Hospitalier Universitaire Dijon is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Pathological Use of Internet Games, CVA, Dijon Registry, Type 2 Diabetes, Foot Wound.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centre Hospitalier Universitaire Dijon
How many clinical trials has Centre Hospitalier Universitaire Dijon sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Centre Hospitalier Universitaire Dijon, of which 13 are actively recruiting participants. These trials cover conditions including Pathological Use of Internet Games, CVA, Dijon Registry, Type 2 Diabetes. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centre Hospitalier Universitaire Dijon research focus on?
Centre Hospitalier Universitaire Dijon clinical trials span Pathological Use of Internet Games, CVA, Dijon Registry, Type 2 Diabetes, Foot Wound, Rare Diseases of Genetic Origin, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Centre Hospitalier Universitaire Dijon clinical trial?
To participate in a Centre Hospitalier Universitaire Dijon trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre Hospitalier Universitaire Dijon trials with current recruitment status updated daily.
Clinical Trials by Centre Hospitalier Universitaire Dijon
NCT04120714
Recruiting
Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming
Pathological Use of Internet Games
NCT04489199
Recruiting
Dijon Stroke Cohort
CVA, Dijon Registry
NCT06630182
Recruiting
Evaluation of the Impact of Psychological Profile on Diabetic Foot Wound Healing. Prospective, Monocentric Study
Type 2 Diabetes
NCT03287193
Recruiting
Identification of the Molecular and/or Pathophysiological Bases of Rare Diseases of Genetic Origin (or Rare Forms of Frequent Diseases Suspected of Being of Genetic Origin).
Rare Diseases of Genetic Origin
NCT05985330
Recruiting
Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer
Metastatic Non-small Cell Lung Cancer
NCT03512132
Recruiting
Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy
Type 1 Diabetes
NCT05457569
Recruiting
Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization
Neurodevelopmental Motor Disorders
NCT04754906
Recruiting
Analysis of Motor Skills in Subjects Aged 55 and Over: the Role of Cognitive Abilities for Planning Movement.
Mild Cognitive Disorder
NCT07564752
Recruiting
The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes
Type 1 Diabetes
NCT06226818
Recruiting
Evaluation of the Impact on Mental and Physical Health of Caring for Women Who Are Victims of Sexual and Gender-based Violence, Using a Coordinated Multidisciplinary Approach in Women's Centres or Traditional Health Centres.
Domestic and/or Sexual Violence
NCT06588010 Phase 3
Recruiting
Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder
Neurogenic Bladder
NCT04940962
Recruiting
Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion
Diabete Type 2
NCT06813976 Phase 3
Recruiting
PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy With Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients With Resected Ampullary Adenocarcinoma
Ampullary Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology